Overview
Cristiano Pini practices practicing medicine in Milan, Italy.
His clinical expertise encompasses Prostate Cancer, Merkel Cell Carcinoma, Lung Nodules, and Lung Cancer.
He is actively involved in clinical research, co-authoring 29 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Cristiano Pini
Is Cristiano Pini a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Cristiano Pini is classified as an Experienced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Cristiano Pini participate in research or clinical trials?
Yes. Cristiano Pini has published 29 articles and abstracts on conditions like Prostate Cancer. You can view a list of Cristiano Pini's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung CancerMr. Pini isExperienced. Learn about Lung Cancer.
- Lung NodulesMr. Pini isExperienced. Learn about Lung Nodules.
- Merkel Cell CarcinomaMr. Pini isExperienced. Learn about Merkel Cell Carcinoma.
- Prostate CancerMr. Pini isExperienced. Learn about Prostate Cancer.